[144/A] CompoSecure, Inc. SEC Filing
Form 144/A notice documents a proposed sale of 100,000 common shares through Edward Jones with an aggregate market value of $1,796,000.00 and an indicated trading venue of Nasdaq. The filing lists 102,317,852 shares outstanding and an approximate sale date of 08/12/2025. The securities to be sold were acquired as restricted stock units: 62,500 vested on 01/01/2023 and 37,500 vested on 01/01/2024, both shown as vesting from Composecure Inc. The form reports "Nothing to Report" for sales in the past three months and includes the standard signature representation about absence of undisclosed material adverse information. Several administrative fields (filer and issuer name/details and signature/date) are not populated in the visible content.
Avviso Modulo 144/A documenta una proposta di vendita di 100.000 azioni ordinarie tramite Edward Jones con un valore di mercato complessivo di $1.796.000,00 e un mercato di negoziazione indicato come Nasdaq. Il deposito indica 102.317.852 azioni in circolazione e una data approssimativa di vendita del 08/12/2025. I titoli da vendere sono stati acquisiti come unit脿 di azioni vincolate (RSU): 62.500 sono maturate il 01/01/2023 e 37.500 il 01/01/2024, entrambe risultano maturate da Composecure Inc. Il modulo riporta "Nothing to Report" per vendite negli ultimi tre mesi e include la consueta dichiarazione di firma relativa all'assenza di informazioni materiali sfavorevoli non divulgate. Alcuni campi amministrativi (nome/dettagli del dichiarante e dell'emittente e firma/data) non sono compilati nel contenuto visibile.
Aviso Formulario 144/A documenta una propuesta de venta de 100.000 acciones ordinarias a trav茅s de Edward Jones con un valor de mercado agregado de $1,796,000.00 y un mercado de negociaci贸n indicado como Nasdaq. La presentaci贸n lista 102,317,852 acciones en circulaci贸n y una fecha aproximada de venta del 08/12/2025. Los valores a vender se adquirieron como unidades de acciones restringidas: 62,500 adquiridas el 01/01/2023 y 37,500 el 01/01/2024, ambas procedentes de Composecure Inc. El formulario informa "Nothing to Report" respecto a ventas en los 煤ltimos tres meses e incluye la representaci贸n de firma est谩ndar sobre la ausencia de informaci贸n adversa material no divulgada. Varios campos administrativos (nombre/detalles del declarante y del emisor y firma/fecha) no est谩n completados en el contenido visible.
Form 144/A 韱奠电� Edward Jones毳� 韱淀暣 齑� 鞁滌灔臧�旃橁皜 $1,796,000.00100,000 氤错喌欤�102,317,852欤茧 旮办灛霅橃柎 鞛堦碃, 鞓堨爼 毵る弰鞚检潃 雽�霝� 08/12/2025搿� 響滌嫓霅橃柎 鞛堨姷雼堧嫟. 毵る弰霅� 歃濌秾鞚� 鞝滍暅攵� 欤检嫕 雼渼(RSU)搿� 旆摑霅橃棃鞙茧┌: 62,500欤嫉鐢 01/01/2023鞐� 甓岆Μ頇曥爼(vested)霅橃棃瓿� 37,500欤嫉鐢 01/01/2024鞐� 甓岆Μ頇曥爼霅橃棃鞙茧┌, 霊� 瓯� 氇憪 Composecure Inc鞐愳劀鞚� 甓岆Μ頇曥爼鞙茧 響滌嫓霅橃柎 鞛堨姷雼堧嫟. 鞏戩嫕鞐惖鐢 歆�雮� 3臧滌洈臧� 毵る弰鞐� 雽�頃� "Nothing to Report"搿� 氤搓碃霅橃柎 鞛堨溂氅�, 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒鞚� 攵�鞛棎 甏�頃� 響滌 靹滊獏 歆勳垹鞚� 韽暔頃橁碃 鞛堨姷雼堧嫟. 氇囯獓 頄夓爼 頃(鞁犼碃鞛� 氚� 氚滍枆鞚� 鞚措/靹鸽秬靷暛, 靹滊獏/雮犾)鞚� 響滌嫓霅� 雮挫毄鞐� 旮办瀰霅橃柎 鞛堨 鞎婌姷雼堧嫟.
Avis Formulaire 144/A documente une proposition de vente de 100 000 actions ordinaires via Edward Jones pour une valeur marchande totale de $1,796,000.00 et un lieu de n茅gociation indiqu茅 Nasdaq. Le d茅p么t indique 102,317,852 actions en circulation et une date approximative de vente le 08/12/2025. Les titres 脿 vendre ont 茅t茅 acquis sous forme d'unit茅s d'actions restreintes (RSU) : 62,500 ont 茅t茅 acquises le 01/01/2023 et 37,500 le 01/01/2024, toutes deux indiqu茅es comme provenant de Composecure Inc. Le formulaire indique "Nothing to Report" pour les ventes des trois derniers mois et inclut la d茅claration standard sign茅e relative 脿 l'absence d'informations d茅favorables importantes non divulgu茅es. Plusieurs champs administratifs (nom/d茅tails du d茅clarant et de l'茅metteur ainsi que signature/date) ne sont pas renseign茅s dans le contenu visible.
Formular 144/A Hinweis dokumentiert einen geplanten Verkauf von 100.000 Stammaktien 眉ber Edward Jones mit einem aggregierten Marktwert von $1.796.000,00 und dem angegebenen Handelsplatz Nasdaq. Die Einreichung weist 102.317.852 ausstehende Aktien aus und nennt ein ungef盲hres Verkaufsdatum 08/12/2025. Die zum Verkauf stehenden Wertpapiere wurden als Restricted Stock Units erworben: 62.500 sind am 01/01/2023 f盲llig geworden und 37.500 am 01/01/2024, beide als Vesting von Composecure Inc ausgewiesen. Das Formular vermerkt "Nothing to Report" f眉r Verk盲ufe in den letzten drei Monaten und enth盲lt die 眉bliche unterschriebene Erkl盲rung 眉ber das Fehlen nicht offengelegter wesentlicher nachteiliger Informationen. Mehrere Verwaltungsfelder (Name/Angaben des Einreichenden und des Emittenten sowie Unterschrift/Datum) sind im sichtbaren Inhalt nicht ausgef眉llt.
- 100,000 common shares clearly identified for proposed sale with aggregate market value $1,796,000.00
- Securities were acquired via RSU vesting on 01/01/2023 and 01/01/2024, shown as vesting events
- Filing reports "Nothing to Report" for securities sold in the past three months
- The visible filing content does not populate filer identity or complete issuer name/address fields
- No signature or explicit date of notice values are shown in the provided text, limiting verification
- Form text contains minor inconsistencies in naming (e.g., Composecure Inc appears as the RSU source while issuer fields are blank)
Insights
TL;DR: Routine Rule 144/A notice for vested RSUs; specified sale appears procedural and not materially disruptive.
The filing shows a proposed sale of 100,000 common shares through Edward Jones with an aggregate market value of $1.796M and identifies the shares as resulting from RSU vesting on 01/01/2023 and 01/01/2024. The form records no sales in the prior three months. As presented, this is a standard disclosure of intent to sell restricted stock under Rule 144 rather than a corporate financing or strategic transaction; the document provides limited operational or financial detail about the issuer itself.
TL;DR: Administrative filing includes required representations but some issuer/filer fields are not populated in the visible content.
The notice contains the required statement that the person signing does not possess undisclosed material adverse information and references Rule 10b5-1 trading-plan language if applicable. However, key administrative fields (filer identity, issuer name/address and signature/date entries) are not shown in the provided text, limiting transparency about the selling party and the formal execution of the notice. The lack of populated filer/issuer fields reduces the filing's standalone clarity for investors.
Avviso Modulo 144/A documenta una proposta di vendita di 100.000 azioni ordinarie tramite Edward Jones con un valore di mercato complessivo di $1.796.000,00 e un mercato di negoziazione indicato come Nasdaq. Il deposito indica 102.317.852 azioni in circolazione e una data approssimativa di vendita del 08/12/2025. I titoli da vendere sono stati acquisiti come unit脿 di azioni vincolate (RSU): 62.500 sono maturate il 01/01/2023 e 37.500 il 01/01/2024, entrambe risultano maturate da Composecure Inc. Il modulo riporta "Nothing to Report" per vendite negli ultimi tre mesi e include la consueta dichiarazione di firma relativa all'assenza di informazioni materiali sfavorevoli non divulgate. Alcuni campi amministrativi (nome/dettagli del dichiarante e dell'emittente e firma/data) non sono compilati nel contenuto visibile.
Aviso Formulario 144/A documenta una propuesta de venta de 100.000 acciones ordinarias a trav茅s de Edward Jones con un valor de mercado agregado de $1,796,000.00 y un mercado de negociaci贸n indicado como Nasdaq. La presentaci贸n lista 102,317,852 acciones en circulaci贸n y una fecha aproximada de venta del 08/12/2025. Los valores a vender se adquirieron como unidades de acciones restringidas: 62,500 adquiridas el 01/01/2023 y 37,500 el 01/01/2024, ambas procedentes de Composecure Inc. El formulario informa "Nothing to Report" respecto a ventas en los 煤ltimos tres meses e incluye la representaci贸n de firma est谩ndar sobre la ausencia de informaci贸n adversa material no divulgada. Varios campos administrativos (nombre/detalles del declarante y del emisor y firma/fecha) no est谩n completados en el contenido visible.
Form 144/A 韱奠电� Edward Jones毳� 韱淀暣 齑� 鞁滌灔臧�旃橁皜 $1,796,000.00100,000 氤错喌欤�102,317,852欤茧 旮办灛霅橃柎 鞛堦碃, 鞓堨爼 毵る弰鞚检潃 雽�霝� 08/12/2025搿� 響滌嫓霅橃柎 鞛堨姷雼堧嫟. 毵る弰霅� 歃濌秾鞚� 鞝滍暅攵� 欤检嫕 雼渼(RSU)搿� 旆摑霅橃棃鞙茧┌: 62,500欤嫉鐢 01/01/2023鞐� 甓岆Μ頇曥爼(vested)霅橃棃瓿� 37,500欤嫉鐢 01/01/2024鞐� 甓岆Μ頇曥爼霅橃棃鞙茧┌, 霊� 瓯� 氇憪 Composecure Inc鞐愳劀鞚� 甓岆Μ頇曥爼鞙茧 響滌嫓霅橃柎 鞛堨姷雼堧嫟. 鞏戩嫕鞐惖鐢 歆�雮� 3臧滌洈臧� 毵る弰鞐� 雽�頃� "Nothing to Report"搿� 氤搓碃霅橃柎 鞛堨溂氅�, 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒鞚� 攵�鞛棎 甏�頃� 響滌 靹滊獏 歆勳垹鞚� 韽暔頃橁碃 鞛堨姷雼堧嫟. 氇囯獓 頄夓爼 頃(鞁犼碃鞛� 氚� 氚滍枆鞚� 鞚措/靹鸽秬靷暛, 靹滊獏/雮犾)鞚� 響滌嫓霅� 雮挫毄鞐� 旮办瀰霅橃柎 鞛堨 鞎婌姷雼堧嫟.
Avis Formulaire 144/A documente une proposition de vente de 100 000 actions ordinaires via Edward Jones pour une valeur marchande totale de $1,796,000.00 et un lieu de n茅gociation indiqu茅 Nasdaq. Le d茅p么t indique 102,317,852 actions en circulation et une date approximative de vente le 08/12/2025. Les titres 脿 vendre ont 茅t茅 acquis sous forme d'unit茅s d'actions restreintes (RSU) : 62,500 ont 茅t茅 acquises le 01/01/2023 et 37,500 le 01/01/2024, toutes deux indiqu茅es comme provenant de Composecure Inc. Le formulaire indique "Nothing to Report" pour les ventes des trois derniers mois et inclut la d茅claration standard sign茅e relative 脿 l'absence d'informations d茅favorables importantes non divulgu茅es. Plusieurs champs administratifs (nom/d茅tails du d茅clarant et de l'茅metteur ainsi que signature/date) ne sont pas renseign茅s dans le contenu visible.
Formular 144/A Hinweis dokumentiert einen geplanten Verkauf von 100.000 Stammaktien 眉ber Edward Jones mit einem aggregierten Marktwert von $1.796.000,00 und dem angegebenen Handelsplatz Nasdaq. Die Einreichung weist 102.317.852 ausstehende Aktien aus und nennt ein ungef盲hres Verkaufsdatum 08/12/2025. Die zum Verkauf stehenden Wertpapiere wurden als Restricted Stock Units erworben: 62.500 sind am 01/01/2023 f盲llig geworden und 37.500 am 01/01/2024, beide als Vesting von Composecure Inc ausgewiesen. Das Formular vermerkt "Nothing to Report" f眉r Verk盲ufe in den letzten drei Monaten und enth盲lt die 眉bliche unterschriebene Erkl盲rung 眉ber das Fehlen nicht offengelegter wesentlicher nachteiliger Informationen. Mehrere Verwaltungsfelder (Name/Angaben des Einreichenden und des Emittenten sowie Unterschrift/Datum) sind im sichtbaren Inhalt nicht ausgef眉llt.
FAQ
What sale does the CMPO 144/A notice disclose?
When is the approximate sale date listed in the filing for CMPO?
How were the shares to be sold acquired according to the form?
Which broker is named for the proposed sale in the CMPO filing?
Does the filing show recent sales by the reporting person?
Who is identified as the issuer in the filing?
